we have studied the activity of sodium-lithium countertransport in red cells , a marker of risk for essential hypertension , in white european adults with insulin-dependent diabetes and diabetic nephropathy , a matched group of patients with diabetes without renal disease , and nondiabetic patients with renal disease .
C0023870
lithium
C0022658
renal disease